What additional vasopressors or inotropes should be added for a hypotensive patient already receiving norepinephrine?

Add Vasopressin or Epinephrine as Second-Line Agent

For a patient with palpatory blood pressure already on norepinephrine, add vasopressin (0.03 units/minute) as the preferred second-line agent, or alternatively add epinephrine if vasopressin is unavailable. 1

Algorithmic Approach to Additional Vasopressor Selection

First: Assess the Clinical Context

The choice of additional agent depends on the underlying shock etiology:

For Distributive/Septic Shock (most common):

• Add vasopressin up to 0.03 units/minute to norepinephrine with the intent of either raising MAP to target (≥65 mmHg) or decreasing norepinephrine dosage 1
• Alternatively, add epinephrine if vasopressin is unavailable or contraindicated 1
• The Surviving Sepsis Campaign guidelines position both as acceptable second-line options, though vasopressin has moderate quality evidence while epinephrine has low quality evidence 1

For Cardiogenic Shock with Myocardial Depression:

• If evidence of poor cardiac output and tissue hypoperfusion persists despite adequate MAP, add dobutamine (up to 20 μg/kg/min) rather than escalating vasopressors 2, 1
• Alternatively, switch to epinephrine as a single agent (provides both vasopressor and inotropic effects) 2
• Avoid pure vasopressors in this context as they increase afterload and worsen cardiac output 2

Second: Specific Clinical Scenarios

If patient has bradycardia or low risk of tachyarrhythmias:

• Consider dopamine as an alternative, though this is generally not preferred due to higher arrhythmia risk 1

If norepinephrine is causing serious arrhythmias:

• Phenylephrine may be used, but only in this specific circumstance or when cardiac output is known to be high 1
• Phenylephrine is otherwise NOT recommended as it lacks inotropic support 1

If refractory shock persists despite norepinephrine + vasopressin/epinephrine:

• Consider angiotensin II for rapid resuscitation in profoundly hypotensive patients 3, 4
• Consider hydrocortisone 200 mg/day if hemodynamic stability cannot be achieved with vasopressors alone 1

Critical Pitfalls to Avoid

⚠️ Do NOT use low-dose dopamine for "renal protection" - this is explicitly contraindicated with strong evidence 1

⚠️ Do NOT exceed vasopressin 0.03-0.04 units/minute - higher doses should be reserved only for salvage therapy when all other agents have failed 1

⚠️ Do NOT use phenylephrine routinely - it is a last-resort agent except in specific circumstances (arrhythmias from norepinephrine, documented high cardiac output) 1

⚠️ Ensure adequate volume resuscitation first - vasopressors should not substitute for fluid resuscitation in hypovolemic patients 5

Practical Dosing Guidance

Vasopressin:

• Start at 0.01-0.03 units/minute (fixed dose, not titrated)
• Do not exceed 0.03-0.04 units/minute for routine use 1

Epinephrine:

• Start at 0.05-0.2 μg/kg/min
• Titrate to effect, monitoring for tachycardia and arrhythmias 2

Dobutamine (if cardiac dysfunction present):

• Start at 2.5-5 μg/kg/min
• Titrate up to 20 μg/kg/min based on perfusion markers 1
• Reduce or discontinue if worsening hypotension or arrhythmias occur 1

Monitoring Requirements

• Place arterial catheter immediately if not already present - this is essential for accurate titration of multiple vasopressors 1
• Monitor perfusion markers beyond MAP: lactate clearance, urine output, mental status, skin perfusion 2
• Consider cardiac output monitoring (ultrasound/echocardiography) to guide inotrope vs. vasopressor decisions 2

The evidence strongly supports a stepwise approach: norepinephrine first, then add vasopressin or epinephrine as second-line agents, with the specific choice guided by shock etiology and patient-specific factors 1. Recent literature suggests early addition of complementary vasopressors may be beneficial rather than escalating norepinephrine to very high doses 6, 7.